Search Results 1441-1450 of 18217 for Lupus

1. Neoadjuvant Pembrolizumab - Mayo Clinic

   ... lupus erythematosus, autoimmune vasculitis [eg, Wegener's Granulomatosis]); motor neuropathy considered of autoimmune origin (e.g. Guillain-Barre Syndrome ...

2. TN-401, A Recombinant Adeno-associated Virus Serotype 9 (AAV9) Containing Plakophilin-2 (PKP2) Transgene, In Adults With PKP2 Mutation-associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) - Mayo Clinic

   ... lupus erythematosus), immunosuppressive disorder, active psychiatric illness, or other clinically significant disorder at Screening, as determined by the ...

3. A Study of Everolimus with or without Bevacizumab for Treating Patients with Advanced Kidney Cancer that Progressed after First-Line Therapy - Mayo Clinic

   Everolimus may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as bevacizumab, can interfere ...

4. Mayo Clinic

   I've been on staff at the Mayo Clinic since 1997 and my whole career has really been focused on treating cancer. I'm Dr. Steven Alberts.

5. Daratumumab in Primary Antiphospholipid Syndrome (DARE-APS) - Mayo Clinic

   Systemic lupus erythematosus (SLE) meeting the EULAR/ACR criteria;; Rheumatoid arthritis meeting the ACR/EULAR classification criteria;; Small, medium, or ...

6. Lichen sclerosus - Symptoms and causes - Mayo Clinic

   Learn more about the causes, symptoms, complications, treatment and self-care tips for this blotchy skin condition that affects the genital and anal areas.

7. Meet The Faculty - Dermatology Residency (Arizona) - Mayo Clinic College of Medicine & Science

   Stella Chen, M.D. · Hidradenitis suppurative · Connective tissue disorders · Dermatomyositis · Lupus · Morphea · Acne · Psoriasis · Skin of color.

8. Rituximab Plus Lenalidomide for Patients With Relapsed / Refractory Indolent Non-Hodgkin's Lymphoma (Follicular Lymphoma and Marginal Zone Lymphoma) - Mayo Clinic

   This double-blind randomized, parallel group study will evaluate the efficacy and safety of lenalidomide (Revlimid, CC-5013) in combination with rituximab ( ...

9. A Study to Assess the Effectiveness and Safety of Brensocatib in Participants With Non-Cystic Fibrosis Bronchiectasis - Mayo Clinic

   ... lupus, inflammatory bowel disease, rheumatoid arthritis, etc.), other severe endocrinologic, gastrointestinal, metabolic, pulmonary, or lymphatic diseases ...

10. Lymphoma - Doctors and departments - Mayo Clinic

    Find out more about the symptoms, diagnosis and treatment of this cancer of the lymphatic system.